News for hackers. Stuff that matters.
Re:Goldman Sachs questions whether curing patients is a sust... by andrepd on Friday April 13, 2018 @12:58PM (#16831771)
You can theorise all you want, but the world is rife with examples of what I said being true. As always, experiment must trump theory.
Re:Goldman Sachs questions whether curing patients is a sust... by andrewla on Friday April 13, 2018 @01:08PM (#16831861)
Certainly there are lots of cases of expensive long-term treatments being developed.

Do you have examples of situations where cures have been suppressed in favor of expensive long-term treatments? Especially in a competitive environment, where there were multiple players offering competing long-term treatments that were both aware of cures?

Preferably this would be something supported by leaked or court documents, but independent investigations would also be interesting. I understand this is a high burden of proof, but everything I've seen seems to indicate that this is an urban myth. I certainly couldn't find any specific cases in a cursory search.

Re:Goldman Sachs questions whether curing patients is a sust... by darawk on Friday April 13, 2018 @01:55PM (#16832308)
Name literally one example of that being true. I'll wait.
Re:Goldman Sachs questions whether curing patients is a sust... by Zooper on Friday April 13, 2018 @05:02PM (#16833882)
Re:Goldman Sachs questions whether curing patients is a sust... by darawk on Friday April 13, 2018 @06:28PM (#16834440)
In what way is sales and marketing spend related?